In people with early Parkinson’s disease, buntanetap slowed cognitive decline, with the biggest gains seen in those with mild dementia. Researchers also noted that about a quarter of these patients showed signs of amyloid buildup — a marker linked to Alzheimer’s disease — and…

Annovis Bio has scheduled a January meeting with the U.S. Food and Drug Administration (FDA) to discuss buntanetap as a treatment for dementia due to Parkinson’s disease. The meeting will include discussions about potential clinical trial design, the criteria that will be used to determine which patients…

I joined a caregiver support group a few years ago, and we meet monthly via Zoom. We are a group of spouses discussing the challenges of caregiving, life, and living with Parkinson’s disease. Our leader and founder is a lovely lady named Diana Dunetz. I was lucky enough to…

Researchers have uncovered a previously overlooked type of electrical brain activity — an irregular signal they call noise — that closely tracks the severity of motor symptoms in people with Parkinson’s disease. The discovery, made by scientists at the Max Planck Institute in Germany, in collaboration with research teams…

While more than 10 million people are estimated to be living with Parkinson’s disease globally, many people still don’t know much about it. My grandfather was diagnosed with Parkinson’s in his 70s, yet I knew very little about its symptoms or treatments until I was also diagnosed with it.